VAULT BIOVENTURES
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Sept 2025)
What this means for you
This application is over — abandoned 22 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97639433
- Mark type
- Stylized text
- Filed
- 19 Oct 2022
- Published for opposition
- 24 Dec 2024
- Abandoned
- 22 Sept 2025
- Attorney of record
- Barry F. Soalt
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of viral and infectious diseases, allergies, diabetes, and for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood, weight, pregnancy and immune system related diseases and disorders, all for the purpose of integrating digital and biopharmaceutical therapeutics to increase health-span and life-span for all humanity
- Class 042 — Scientific and technological services: Pharmaceutical product development services; Pharmaceutical research services
Owner
- Vault Bioventures, Inc., San Diego, CA, US
- Vault Bioventures, Inc., San Diego, CA, US
Prior registrations
Prosecution history
- 22 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Dec 2024 — PUBLISHED FOR OPPOSITION
- 18 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 26 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 26 Nov 2024 — EXAMINERS AMENDMENT E-MAILED
- 26 Nov 2024 — EXAMINERS AMENDMENT -WRITTEN
- 07 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Nov 2024 — ASSIGNED TO LIE
- 16 Aug 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED